Matrix Selection for the Visualization of Small Molecules and Lipids in Brain Tumors Using Untargeted MALDI-TOF Mass Spectrometry Imaging

Author:

Lu Tianyao12,Freytag Lutz1ORCID,Narayana Vinod K.3ORCID,Moore Zachery12ORCID,Oliver Shannon J.1,Valkovic Adam1,Nijagal Brunda3,Peterson Amanda L.3,de Souza David P.3ORCID,McConville Malcolm J.34ORCID,Whittle James R.125,Best Sarah A.12ORCID,Freytag Saskia12

Affiliation:

1. Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne 3052, Australia

2. Department of Medical Biology, University of Melbourne, Melbourne 3052, Australia

3. Metabolomics Australia, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne 3010, Australia

4. Department of Biochemistry and Molecular Biology, Bio21 Institute of Molecular Science and Biotechnology, University of Melbourne, Melbourne 3010, Australia

5. Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne 3052, Australia

Abstract

Matrix-assisted laser desorption/ionization mass spectrometry imaging allows for the study of metabolic activity in the tumor microenvironment of brain cancers. The detectable metabolites within these tumors are contingent upon the choice of matrix, deposition technique, and polarity setting. In this study, we compared the performance of three different matrices, two deposition techniques, and the use of positive and negative polarity in two different brain cancer types and across two species. Optimal combinations were confirmed by a comparative analysis of lipid and small-molecule abundance by using liquid chromatography–mass spectrometry and RNA sequencing to assess differential metabolites and enzymes between normal and tumor regions. Our findings indicate that in the tumor-bearing brain, the recrystallized α-cyano-4-hydroxycinnamic acid matrix with positive polarity offered superior performance for both detected metabolites and consistency with other techniques. Beyond these implications for brain cancer, our work establishes a workflow to identify optimal matrices for spatial metabolomics studies.

Funder

Carrie’s Beanies 4 Brain Cancer

Cancer Australia

Cancer Council Victoria Venture Grant

Perpetual Philanthropic Grant

Victorian State Government Operational Infrastructure Support

Australian Government NHMRC Independent Research Institutes Infrastructure Support Scheme

Victorian Cancer Agency Mid-Career Research Fellowship

National Health and Medical Research Council of Australia (NHMRC) Ideas Grant

Publisher

MDPI AG

Subject

Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference47 articles.

1. Metabolism of [U-13C]Glucose in Human Brain Tumors in Vivo;Maher;NMR Biomed.,2012

2. Tests on Surviving Carcinoma Cultures;Warburg;Biochem. Z.,1923

3. An Integrated Genomic Analysis of Human Glioblastoma Multiforme;Parsons;Science,2008

4. IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas;Watanabe;Am. J. Pathol.,2009

5. Analysis of the IDH1 Codon 132 Mutation in Brain Tumors;Balss;Acta Neuropathol.,2008

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3